Baseline, 6 month, mean change and treatment effect data for all outcomes (excluding patients with CRP values >8 at baseline or follow-up)
| Standard Care | CPAP | Treatment effect (95% CI) | p-Value | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | Baseline | 6 Months | Mean change (SD) | N | Baseline | 6 Months | Mean change (SD) | |||
| Highly sensitive CRP (mg/L) | 113 | 1.56 (0.84–3.48) | 1.66 (0.87–3.44) | 0.03 (1.78) | 125 | 1.86 (0.84–3.32) | 1.49 (0.82–2.75) | −0.19 (1.56) | −0.20 (−0.59, 0.18) | 0.30 |
| Interleukin 6 (pg/mL) | 111 | 0.48 (0.19–0.92) | 0.58 (0.26–1.09) | 0.14 (0.61) | 125 | 0.44 (0.24–0.79) | 0.52 (0.22–0.96) | 0.11 (0.45) | −0.04 (−0.17, 0.10) | 0.62 |
| Interleukin 10 (pg/mL) | 111 | 0.59 (0.33–1.02) | 0.70 (0.39–1.21) | 0.11 (1.22) | 125 | 0.61 (0.29–1.01) | 0.60 (0.33–1.04) | 0.48 (2.50) | 0.35 (−0.12, 0.83) | 0.14 |
| Tumour necrosis factor (pg/mL) | 111 | 0.96 (0.45–1.35) | 1.07 (0.48–1.48) | 0.10 (0.40) | 125 | 1.01 (0.45–1.35) | 1.17 (0.61–1.56) | 0.15 (0.39) | 0.05 (−0.05, 0.15) | 0.37 |